Literature DB >> 25393187

Legal Authority for Infectious Disease Reporting in the United States: Case Study of the 2009 H1N1 Influenza Pandemic.

Richard N Danila1, Ellen S Laine, Franci Livingston, Kathryn Como-Sabetti, Lauren Lamers, Kelli Johnson, Anne M Barry.   

Abstract

Tracking of infectious diseases is a public health core function essential to disease prevention and control. Each state mandates reporting of certain infectious diseases to public health authorities. These laws vary by state, and the variation could affect the ability to collect critical information. The 2009 H1N1 influenza pandemic served as a case study to examine the legal authority in the 50 states; Washington, DC; and New York City for mandatory infectious disease reporting, particularly for influenza and new or emerging infectious diseases. Our study showed reporting laws to be generally present and functioning well; nevertheless, jurisdictions should be mindful of their mandated parameters and review the robustness of their laws before they face a new or emerging disease outbreak.

Entities:  

Year:  2015        PMID: 25393187      PMCID: PMC4265911          DOI: 10.2105/AJPH.2014.302192

Source DB:  PubMed          Journal:  Am J Public Health        ISSN: 0090-0036            Impact factor:   9.308


  15 in total

1.  Mandatory reporting of diseases and conditions by health care professionals and laboratories.

Authors:  S Roush; G Birkhead; D Koo; A Cobb; D Fleming
Journal:  JAMA       Date:  1999-07-14       Impact factor: 56.272

2.  Public health. Surveillance and privacy.

Authors:  R Bayer; A L Fairchild
Journal:  Science       Date:  2000-12-08       Impact factor: 47.728

3.  Critical biological agents: disease reporting as a tool for determining bioterrorism preparedness.

Authors:  Heather H Horton; James J Misrahi; Gene W Matthews; Paula L Kocher
Journal:  J Law Med Ethics       Date:  2002       Impact factor: 1.718

4.  Deaths related to 2009 pandemic influenza A (H1N1) among American Indian/Alaska Natives - 12 states, 2009.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2009-12-11       Impact factor: 17.586

5.  Challenging custom: rethinking national population surveillance policy in a global public health age.

Authors:  Rebecca Katz; Sara Rosenbaum
Journal:  J Health Polit Policy Law       Date:  2010-12       Impact factor: 2.265

6.  Improving the evidence base for decision making during a pandemic: the example of 2009 influenza A/H1N1.

Authors:  Marc Lipsitch; Lyn Finelli; Richard T Heffernan; Gabriel M Leung; Stephen C Redd
Journal:  Biosecur Bioterror       Date:  2011-06

7.  US school morbidity and mortality, mandatory vaccination, institution closure, and interventions implemented during the 2009 influenza A H1N1 pandemic.

Authors:  Terri Rebmann; Michael B Elliott; Zachary Swick; David Reddick
Journal:  Biosecur Bioterror       Date:  2013-03-08

Review 8.  Design and operation of state and local infectious disease surveillance systems.

Authors:  Richard S Hopkins
Journal:  J Public Health Manag Pract       Date:  2005 May-Jun

9.  Ethical justification for conducting public health surveillance without patient consent.

Authors:  Lisa M Lee; Charles M Heilig; Angela White
Journal:  Am J Public Health       Date:  2011-11-28       Impact factor: 9.308

10.  Pandemic (H1N1) 2009 surveillance for severe illness and response, New York, New York, USA, April-July 2009.

Authors:  Sharon Balter; Leena S Gupta; Sungwoo Lim; Jie Fu; Sharon E Perlman
Journal:  Emerg Infect Dis       Date:  2010-08       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.